Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Patrocinado

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Postado

98

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Faça Login para curtir, compartilhar e comentar!

RBSE Science, Commerce Results 2025: High pass percentages, Girls outshine boys again

Por 0 5

Public hope towards Maoist increasing: Chair Dahal

BAGLUNG: CPN (Maoist Centre) chair Pushpa Kamal Dahal ‘Prachanda’ has stated that the...

Por 0 17

Baburam Bhattarai walks off stage after controversial remark on armed conflict deaths sparks protest

KATHMANDU: Former Prime Minister Dr. Baburam Bhattarai faced backlash and was forced to...

Por 0 18

Suniel Shetty apologises for comfort of C-section comment

Actor Suniel Shetty has stepped forward to clarify his recent remarks regarding daughter Athiya...

Por 0 44

UN walks back 14,000 Gaza baby death claim after backlash

The UN faced backlash after its humanitarian chief, Tom Fletcher, stated 14,000 Gaza babies could...

Por 0 46